GL1X · GenesisL1 explorer

Research workbench

Crystal structure of PTPN3 (PTPH1) D811E mutant in complex with metavanadate

Analyse Crystal structure of PTPN3 (PTPH1) D811E mutant in complex with metavanadate in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4RI5
Type
protein
Length
568 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein phosphatase non-receptor type 3
EC
3.1.3.48
UniProt
P26045
Ligands
VN4
Pockets
5 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BTyrosine-protein phosphatase non-receptor type 3 (EC 3.1.3.48)protein28437% helix, 24% strandP26045

Ligands and binding sites

  • VN4 · oxido(dioxo)vanadium · ligand · 2 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18240.740.7984GOL, VN4
21520.490.7719empty
31030.420.7718empty
4500.400.8214empty
5530.270.7416empty

Interfaces

1 interface between chains.

  • A–B · 466 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 4RI5 · Crystal structure of PTPN3 (PTPH1) D811E mutant in complex with metavanadate · the same entry in another collection · chain B against B, TM-score 1.00
  • P26045 · AlphaFold monomer V2.0 prediction for tyrosine-protein phosphatase non-receptor type 3… · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.